News and Trends 17 Mar 2023
How cancer cells repair DNA damage from radiotherapy
A team of scientists led by Kei-ichi Takata from the Center for Genomic Integrity (CGI) within the Institute for Basic…
South Korea
- Latest Posts
News and Trends 28 Feb 2023
GC Biopharma acquiring hemophilia rare disease pipeline
GC Biopharma Corp., a South Korean provider of biopharmaceutical products, has signed an asset purchase agreement with Catalyst Biosciences to…
News and Trends 23 Feb 2023
Korean researchers develop antimicrobial peptides discovery tool
Antimicrobial peptides (AMPs) are a promising new weapon for combating the growing antimicrobial resistance (AMR) of bacteria and other harmful…
News and Trends 2 Feb 2023
Possible drug targets from Korean atherosclerosis research
Research suggests that the enzyme phosphoenolpyruvate carboxykinase 2 (PCK2) and its gene play a role in the development of vascular…
ADVERTISEMENT
News and Trends 20 Jan 2023
New drug could replace current standard for treating brain cancer
Glioblastoma (GBM) is a WHO grade IV brain tumor with dismal prognosis. Although post-surgical radiation chemotherapy combined with temozolomide is…
News and Trends 19 Jan 2023
GPCR Therapeutics launches multiple myeloma trial
GPCR Therapeutics, Inc., a drug discovery company targeting G Protein Coupled Receptors (GPCR) pairs, has started its phase 2 trial…
News and Trends 13 Dec 2022
Therabest and Glycotope to assess breast cancer combination treatment
Therabest USA. Inc, Therabest Korea and Glycotope GmbH have signed an agreement to assess the clinical development of Therabest’s EiNK…
News and Trends 5 Dec 2022
New company Liminatus Pharma Inc to develop three cancer treatments
Clinical-stage biopharma company Liminatus Pharma LLC and Iris Acquisition Corp, a publicly traded special purpose acquisition company formed for the…
News and Trends 5 Dec 2022
MaxCyte and Curamys sign cell and gene therapies agreement
MaxCyte, Inc. and Curamys have announced the signing of a strategic platform license. MaxCyte is a cell-engineering focused company providing…
News and Trends 13 Oct 2022
Adalta and GPCR Therapeutics to collaborate on novel cancer treatments
AdAlta Limited and GPCR Therapeutics Inc, are set to collaborate to evaluate AdAlta’s CXCR4 inhibiting i‑bodies as cancer therapeutics, using…
ADVERTISEMENT
In Depth 7 Sep 2022
The biggest private biotech investments in August 2022
The healthcare-focused companies Orna Therapeutics, F2G and Sironax bagged the biggest biotech investments in August 2022, with mRNA vaccines, genomics…
News and Trends 10 Aug 2022
Stem cell therapy to be used in treatment of long COVID by Panacell Biotech
A South Korean biotech company says it will use natural killer (NK) cells, exosomes and brown adipose-derived stem cells (ADSC)…
News and Trends 20 Jul 2022
IVI and Moderna sign MOU for vaccine R&D
The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable…
News and Trends 19 Jul 2022
SK Bioscience signs deal with Novavax to manufacture COVID-19 vaccine
South Korean company SK Bioscience has extended its partnership with Novavax, Inc., a U.S. biotechnology company specializing in next-generation vaccines,…
News and Trends 14 Jul 2022
GenScript ProBio enters strategic partnerships with two South Korean biotechs
GenScript ProBio, the CDMO segment of the leading biotech GenScript, has entered into a strategic partnership memorandum of understanding (MOU)…
News and Trends 12 Jul 2022
Legochem Bioscience signs agreement with Glycotope to develop cancer drug
A company from South Korea has signed a research collaboration and license agreement with a German business to develop a…